Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CEMI Hot Sheet
Price: $0.46 --0%
Financial Fact:
Basic net income per share: -0.19
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Basic net income per share: -0.19
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Chembio Diagnostics (NASDAQ: CEMI) reported Q3 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.75 million versus the consensus estimate of $3.76 million.
For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
